CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) [NA]
Summary
A pivotal clinical trial evaluating the SUpira System for patients undergoing high-risk percutaneous coronary intervention in coronary artery disease is current…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Supira Medical | Conditions: Coronary Artery Disease, High Risk Percutaneous Coronary Intervention | NA | Status: NOT_YET_RECRUITING